Acute Myelogenous Regimens

DISEASE: Acute Myelogenous

Select a REGIMEN:

A+D(7+3)(INDUCTION)
A+D+E(7+3+7)(INDUCTION)
HiDAC
IDA-AR 1 (INDUCTION)
IDA-AR 2 (CONSOLIDATION)
MC (INDUCTION)

DISEASE: Acute Myelogenous

REGIMEN: A+D(7+3)(INDUCTION)

CYTARABINE

DAUNORUBICIN [DNR] 45 mg/m2 per day IV...D1-3
Caution: Monitor cumulative dose (cardiac toxicity) Note: Repeat for further induction or consolidation with cytarabine x 5 days and daunorubicin x 2 days

CYCLE: None
REFER: Dillman RO, et al: BLOOD 1991; 78:2520-2526.

DISEASE: Acute Myelogenous

REGIMEN: A+D+E(7+3+7)(INDUCTION)

CYTARABINE

DAUNORUBICIN [DNR] 50 mg/m2 per day IV...D1-3
Caution: Monitor cumulative dose (cardiac toxicity)

ETOPOSIDE [VP-16] 75 mg/m2 per day IV/1 hr...D1-7

CYCLE: Induction
REFER: Bishop J, et al: BLOOD 1990; 1/1 75(1):27-32.

DISEASE: Acute Myelogenous

REGIMEN: HiDAC

CYTARABINE

CYCLE: None
REFER: Bloomfield CD, Herzig GP, eds.: HEMATOLOGY/ONCOLOGY CLINICS OF NORTH AMERICA 1993; 7:47-79.

DISEASE: Acute Myelogenous

REGIMEN: IDA-AR 1 (INDUCTION)

IDARUBICIN

CYTARABINE [ARA-C] 100 mg/m2 per day x 7 CIV...D1-7

CYCLE: None
REFER: Vogler WR, et al: J CLIN ONCOL 1992; 10:1103-1111.

DISEASE: Acute Myelogenous

REGIMEN: IDA-AR 2 (CONSOLIDATION)

THIOGUANINE

CYTARABINE [ARA-C] 100 mg/m2 IV q 12h
x 10 doses

IDARUBICIN [IDA] 15 mg/m2 IV...D1
Caution: Monitor cumulative dose (cardiac toxicity)

CYCLE: 21-28 days x 3 courses
REFER: Vogler WR, et al: J CLIN ONCOL 1992; 10:1103-1111.

DISEASE: Acute Myelogenous

REGIMEN: MC (INDUCTION)

MITOXANTRONE

CYTARABINE [ARA-C] 100 mg/m2 per day x 7 CIV...D1-7

CYCLE: Induction
REFER: Arlin Z, et al: LEUKEMIA 1990; 4:177-183.

Medicine OnLine and UltiTech have no liability for content or goods on the Internet except as set forth in the Terms and Conditions of service.

Please read the Disclaimer of Warranties before using information contained in this section.

[ Top Of Page | Regimens Index | DoseCalc Index ]